Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Italiano

Showing results (181-190 of 418) with videos related to

Pageof 42
Sort By:
The Oncologist|December 2, 2017
Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert SurveyChristian Rothermundt, Galina F Fischer, Sebastian Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2019
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 StudyHyun Cheol Chung, Willeke Ros, Jean-Pierre Delord, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2009
Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sitesCarlos Gomez-Roca, Christophe M Raynaud, Frederique Penault-Llorca, et al.
British Journal of Cancer|March 26, 2025
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trialDesmond Yip, John Zalcberg, Jean-Yves Blay, et al.
Pediatric Blood & Cancer|June 24, 2017
NUT carcinoma in children and adults: A multicenter retrospective studyLauriane Lemelle, Gaëlle Pierron, Paul Fréneaux, et al.
Annals of Surgical Oncology|November 8, 2007
Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy numberAntoine Italiano, Philippe Follana, François-Xavier Caroli, et al.
Breast Cancer Research : BCR|January 2, 2020
A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancerIain R Macpherson, Pavlina Spiliopoulou, Saeed Rafii, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2023
Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case ReportsSophie Moog, Livia Lamartina, Mohamed-Amine Bani, et al.
Journal of Surgical Oncology|January 5, 2019
Distal extremities soft tissue sarcomas: Are they so different from other limb localizations?Jean-Camille Mattei, Véronique Brouste, Philippe Terrier, et al.
Nature Medicine|May 6, 2024
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trialJordi Rodón, Silvia Damian, Muhammad Furqan, et al.
Pageof 42

Showing results (181-190 of 418) with videos related to

Sort By:
Pageof 42
The Oncologist|December 2, 2017
Pre- and Postoperative Chemotherapy in Localized Extremity Soft Tissue Sarcoma: A European Organization for Research and Treatment of Cancer Expert SurveyChristian Rothermundt, Galina F Fischer, Sebastian Bauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 4, 2019
Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 StudyHyun Cheol Chung, Willeke Ros, Jean-Pierre Delord, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 19, 2009
Differential expression of biomarkers in primary non-small cell lung cancer and metastatic sitesCarlos Gomez-Roca, Christophe M Raynaud, Frederique Penault-Llorca, et al.
British Journal of Cancer|March 26, 2025
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trialDesmond Yip, John Zalcberg, Jean-Yves Blay, et al.
Pediatric Blood & Cancer|June 24, 2017
NUT carcinoma in children and adults: A multicenter retrospective studyLauriane Lemelle, Gaëlle Pierron, Paul Fréneaux, et al.
Annals of Surgical Oncology|November 8, 2007
Cetuximab shows activity in colorectal cancer patients with tumors for which FISH analysis does not detect an increase in EGFR gene copy numberAntoine Italiano, Philippe Follana, François-Xavier Caroli, et al.
Breast Cancer Research : BCR|January 2, 2020
A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancerIain R Macpherson, Pavlina Spiliopoulou, Saeed Rafii, et al.
Thyroid : Official Journal of the American Thyroid Association|September 12, 2023
Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case ReportsSophie Moog, Livia Lamartina, Mohamed-Amine Bani, et al.
Journal of Surgical Oncology|January 5, 2019
Distal extremities soft tissue sarcomas: Are they so different from other limb localizations?Jean-Camille Mattei, Véronique Brouste, Philippe Terrier, et al.
Nature Medicine|May 6, 2024
Pemigatinib in previously treated solid tumors with activating FGFR1-FGFR3 alterations: phase 2 FIGHT-207 basket trialJordi Rodón, Silvia Damian, Muhammad Furqan, et al.
Pageof 42